ANTIPLATELET THERAPY
Clinical trials for ANTIPLATELET THERAPY explained in plain language.
Never miss a new study
Get alerted when new ANTIPLATELET THERAPY trials appear
Sign up with your email to follow new studies for ANTIPLATELET THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart bypass gets safer? new drug trial aims to prevent clots during surgery
Disease control Recruiting nowThis study tests whether giving the blood thinner cangrelor during a minimally invasive heart bypass (MIDCAB) is safe and helps prevent dangerous blood clots. About 30 adults with coronary artery disease will receive cangrelor through an IV during surgery, and their outcomes will…
Matched conditions: ANTIPLATELET THERAPY
Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Heart stent patients get personalized blood thinner dosing in new study
Disease control Recruiting nowThis study looks for the best type and dose of a single blood thinner (P2Y12 inhibitor) for people who have had a heart stent placed. About 355 participants will try different doses to find the sweet spot that prevents blood clots without causing dangerous bleeding. The goal is t…
Matched conditions: ANTIPLATELET THERAPY
Phase: PHASE3 • Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated May 20, 2026 11:55 UTC